Safety and Efficacy of Bojungikki-Tang in Advanced NSCLC Patients Receiving Treatment with Immune Checkpoint Inhibitors: Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot TrialMi Mi Ko, Mi-Kyung Jeong, Chang‐Min Choi et al.|International Journal of Environmental Research and Public Health|2023Cited by 7